What happened to knowledge on Monepantel held by Eli Lilly when Eli Lilly divested Elanco.
Did the dossier of data on monepantel/humans stay with Eli Lilly ?
Does this data represent some of the 17,000 pages in the IND submission.
Eli Lilly are throwing massive resources at Neurodegenerative Diseases.
With a big focus around Alzheimer's Disease
AND
They have started investing in ALS.
In June 2024, the transaction below with QurAlis.
USD $45M upfront and $577M in milestones
I can't think of any other entity in a position to contribute to a submission on NUZ-001 in such a major way.
All IMO
Ann: Neurizon Files IND Application to Support HEALEY ALS Trial, page-76
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $81.23M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $193.8K | 1.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 78264 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 49399 | 3 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |